315 related articles for article (PubMed ID: 28976570)
1. Renal Transplant Acute Rejection with Lower Mycophenolate Mofetil Dosing and Proton Pump Inhibitors or Histamine-2 Receptor Antagonists.
Patel KS; Stephany BR; Barnes JF; Bauer SR; Spinner ML
Pharmacotherapy; 2017 Dec; 37(12):1507-1515. PubMed ID: 28976570
[TBL] [Abstract][Full Text] [Related]
2. Influence of Proton Pump Inhibitors on Mycophenolic Acid Pharmacokinetics in Patients With Renal Transplantation and the Relationship With Cytochrome 2C19 Gene Polymorphism.
Ciftci HS; Karadeniz MS; Tefik T; Caliskan Y; Yazıcı H; Demir E; Turkmen A; Nane I; Oguz FS; Aydin F
Transplant Proc; 2017 Apr; 49(3):490-496. PubMed ID: 28340819
[TBL] [Abstract][Full Text] [Related]
3. Proton pump inhibitors do not increase the risk of acute rejection.
van Boekel GA; Kerkhofs CH; van de Logt F; Hilbrands LB
Neth J Med; 2014 Feb; 72(2):86-90. PubMed ID: 24659591
[TBL] [Abstract][Full Text] [Related]
4. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
Anil Kumar MS; Irfan Saeed M; Ranganna K; Malat G; Sustento-Reodica N; Kumar AM; Meyers WC
Transpl Immunol; 2008 Nov; 20(1-2):32-42. PubMed ID: 18773960
[TBL] [Abstract][Full Text] [Related]
5. Proton pump inhibitor co-medication reduces mycophenolate acid drug exposure in heart transplant recipients.
Kofler S; Deutsch MA; Bigdeli AK; Shvets N; Vogeser M; Mueller TH; Meiser B; Steinbeck G; Reichart B; Kaczmarek I
J Heart Lung Transplant; 2009 Jun; 28(6):605-11. PubMed ID: 19481022
[TBL] [Abstract][Full Text] [Related]
6. A prospective analysis of the effects of enteric-coated mycophenolate sodium and mycophenolate mofetil co-medicated with a proton pump inhibitor in kidney transplant recipients at a single institute in China.
Xu L; Cai M; Shi BY; Li ZL; Li X; Jin HL
Transplant Proc; 2014 Jun; 46(5):1362-5. PubMed ID: 24935300
[TBL] [Abstract][Full Text] [Related]
7. Choice of Acid Suppressant Therapy and Long-Term Graft Outcomes After Kidney Transplantation.
January SE; Progar K; Nesselhauf NM; Hagopian JC; Malone AF
Pharmacotherapy; 2020 Nov; 40(11):1082-1088. PubMed ID: 33037663
[TBL] [Abstract][Full Text] [Related]
8. Mycophenolate mofetil for the treatment of a first acute renal allograft rejection: The Mycophenolate Mofetil Acute Renal Rejection Study Group.
Transplantation; 1998 Jan; 65(2):235-41. PubMed ID: 9458021
[TBL] [Abstract][Full Text] [Related]
9. Concomitant proton pump inhibitors with mycophenolate mofetil and the risk of rejection in kidney transplant recipients.
Knorr JP; Sjeime M; Braitman LE; Jawa P; Zaki R; Ortiz J
Transplantation; 2014 Mar; 97(5):518-24. PubMed ID: 24162246
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of low-dose mycophenolate mofetil therapy for Taiwanese renal transplantation patients receiving primary cyclosporine immunosuppression.
Tsai MK; Hu RH; Lee CJ; Lee PH
J Formos Med Assoc; 2002 Sep; 101(9):616-21. PubMed ID: 12645188
[TBL] [Abstract][Full Text] [Related]
11. Tacrolimus plus low-dose mycophenolate mofetil in renal transplant recipients: better 2-year graft and patient survival than with a higher mycophenolate mofetil dose.
Kocak H; Yakupoglu U; Karatas GU; Yavuz A; Gurkan A; Erdogan O; Ersoy FF; Yakupoglu G; Demirbas A; Tuncer M
Transplant Proc; 2005 Sep; 37(7):3009-11. PubMed ID: 16213288
[TBL] [Abstract][Full Text] [Related]
12. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group.
Transplantation; 1996 Apr; 61(7):1029-37. PubMed ID: 8623181
[TBL] [Abstract][Full Text] [Related]
13. The impact of mycophenolate mofetil dosing patterns on clinical outcome after renal transplantation.
Pelletier RP; Akin B; Henry ML; Bumgardner GL; Elkhammas EA; Rajab A; Ferguson RM
Clin Transplant; 2003 Jun; 17(3):200-5. PubMed ID: 12780668
[TBL] [Abstract][Full Text] [Related]
14. Reasons for dose reduction of mycophenolate mofetil during the first year after renal transplantation and its impact on graft outcome.
Vanhove T; Kuypers D; Claes KJ; Evenepoel P; Meijers B; Naesens M; Vanrenterghem Y; Cornelis T; Bammens B
Transpl Int; 2013 Aug; 26(8):813-21. PubMed ID: 23746202
[TBL] [Abstract][Full Text] [Related]
15. Randomized trial of mycophenolate mofetil versus enteric-coated mycophenolate sodium in primary renal transplant recipients given tacrolimus and daclizumab/thymoglobulin: one year follow-up.
Ciancio G; Burke GW; Gaynor JJ; Roth D; Sageshima J; Kupin W; Tueros L; Hanson L; Rosen A; Ruiz P; Miller J
Transplantation; 2008 Jul; 86(1):67-74. PubMed ID: 18622280
[TBL] [Abstract][Full Text] [Related]
16. Routine prophylaxis with proton pump inhibitors and post-transplant complications in kidney transplant recipients undergoing early corticosteroid withdrawal.
Courson AY; Lee JR; Aull MJ; Lee JH; Kapur S; McDermott JK
Clin Transplant; 2016 Jun; 30(6):694-702. PubMed ID: 27004722
[TBL] [Abstract][Full Text] [Related]
17. Initial mycophenolate dose in tacrolimus treated renal transplant recipients, a cohort study comparing leukopaenia, rejection and long-term graft function.
Dave V; Polkinghorne KR; Leong KG; Kanellis J; Mulley WR
Sci Rep; 2020 Nov; 10(1):19379. PubMed ID: 33168923
[TBL] [Abstract][Full Text] [Related]
18. Predictive factors of acute rejection after early cyclosporine withdrawal in renal transplant recipients who receive mycophenolate mofetil: results from a prospective, randomized trial.
Hazzan M; Labalette M; Copin MC; Glowacki F; Provôt F; Pruv FR; Noël C
J Am Soc Nephrol; 2005 Aug; 16(8):2509-16. PubMed ID: 15987748
[TBL] [Abstract][Full Text] [Related]
19. Enteric-coated mycophenolate sodium given in combination with tacrolimus has a lower incidence of serious infections in Asian renal-transplant recipients compared with mycophenolate mofetil.
Feng JJ; Zhang LW; Zhao P; Bow LM; Tian J
Int J Clin Pract Suppl; 2015 May; (183):1-7. PubMed ID: 26176848
[TBL] [Abstract][Full Text] [Related]
20. Effect of the proton-pump Inhibitor pantoprazole on MycoPhenolic ACid exposure in kidney and liver transplant recipienTs (IMPACT study): a randomized trial.
Sunderland A; Russ G; Sallustio B; Cervelli M; Joyce D; Ooi E; Jeffrey G; Boudville N; Chakera A; Dogra G; Chan D; Wong G; Lim WH
Nephrol Dial Transplant; 2020 Jun; 35(6):1060-1070. PubMed ID: 32516810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
